The Food and Drug Administration on Friday approved an Alzheimer’s drug shown in clinical trials to slow cognitive decline in patients in the early stages of the illness.

339620

CTV News

Canada

U.S. approves Alzheimer's drug that modestly slows disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease. The FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticized in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

Media Bias/Fact Check

Times of India

India

US: FDA approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease

News18 India

Mukesh Ambani

New Alzheimer's Disease Treatment Drug Lecanemab Gets US FDA’s Approval

The study also showed that Leqembi carries a risk of brain swelling and bleeding 

Ad Fontes Media

All Sides

The Independent

Evgeny Lebedev

London

Greater London

England

United Kingdom

New hope for Alzheimer’s sufferers as FDA gives fast-track approval to drug

U.S. health officials on Friday approved a closely watched Alzheimer's drug that's been shown to modestly slow the early stages of the brain-robbing disease, albeit with potential safety risks that doctors and patients will have to carefully weigh.

Bell Media

U.S. health officials on Friday approved a closely watched Alzheimer's drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.

CBC News

Government of Canada

U.S. approves Leqembi, a drug that modestly slows Alzheimer's

The drug aims to slow the advance of the neurodegenerative disease. Nearly all previous experimental drugs using the same approach have failed.

Reuters

The Woodbridge Company

Eisai, Biogen get U.S. FDA approval for Alzheimer's drug, apply for full approval

WASHINGTON (AP) — U.S. health officials on Friday approved a closely watched Alzheimer’s drug that’s been shown to modestly slow the early stages of the brain-robbing disease, albeit with potential safety risks that doctors and patients will have to carefully weigh. 

Associated Press News

Independent Media

United States

US approves Alzheimer's drug that modestly slows disease

Preliminary data from a September trial showed the drug slowed cognitive decline by 27% in patients. It also indicated that the treatment risks brain swelling and bleeding among some patients.

Hindustan Times

HT Media

New Delhi

Delhi

US: FDA approves anti-Alzheimer's drug

Federal drug regulators on Friday approved lecanemab, sold under the brand name Leqembi, an Alzheimer’s drug that appears to slow the disease.

USA Today

Gannett

FDA approves new drug lecanemab that appears to slow early, mild Alzheimer's

The FDA has granted accelerated approval to a new Alzheimer's drug.

abc News

The Walt Disney Company

FDA grants accelerated approval to Alzheimer's drug for people with early stage disease

Alzheimer

Alzheimer's Disease

North America

Health

Science

Medical

Washington DC

Washington

District of Columbia

Irish Independent

Sydney Morning Herald

NZ Herald

Washington Times

New York Post

The Washington Post

Metro News

Channel News Asia

CNBC

Infobae

The Telegraph

CBS News

The Hill

Benzinga

The Business Journals

Shropshire Star

Washington Examiner

Financial Post

News12

HuffPost

Bloomberg

Arab News

Anadolu Ajansı

The Mercury news

Business Insider

VOA News

Star Advertiser

Bangkok Post

Le Parisien

Star Tribune

Zeit Online

Gulf News

NBC News

GMA Filipino News

Boston Herald

Portland Press Herald

The Globe & Mail

abc 6 Philadelphia

KCRA 3

abc 7 Chicago

Pioneer Press

Spectrum News

Deutsche Welle

Het Laatste Nieuws

abc 13 Houston

Click on Detroit

Clarin

Irish Examiner

Corriere Della Sera

abc 7 LA

WCVB

abc 7 NY

Medical Xpress

Devdiscourse

WLWT

Barrie Today

abc11 Raleigh

WMUR

Nikkei

La Vanguardia

abc 7 News

Penn Live

abc30 News

Wral News

WLKY

Orillia Matters

Mass Live

WESH

Koco News5

Bangor Daily News

WDSU

KETV

WYFF

WTAE

Newmarket Today

Collingwood Today

読売新聞オンライン

Thorold Today

Elora Fergus Today

KCCI

KMBC

Medscape

WISN

WHDH

WBAL-TV

FDA approves Alzheimer’s drug that slowed cognitive decline in clinical trial

FDA approves Alzheimer’s drug that slowed cognitive decline in clinical trial

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics